top of page
Discover
The Latest From Our PRN Community
Welcome to our blog by PRN members for PRN members, filled with unique and engaging content to explore, connect, and engage with the world of ambulatory care pharmacy!

Search


Making Connections: Networking at the ACCP Annual Meeting as a Pharmacy Student
Written by Sarah Abdulameer, PharmD and Kris Denzel Tupas, PharmD, BCPS, BCACP The Power of Networking in Pharmacy Networking is a cornerstone of professional growth in pharmacy, opening doors to mentorship, collaboration, and career opportunities. The American College of Clinical Pharmacy (ACCP) Annual Meeting is one of the best events that allows pharmacy students to engage with experts, explore various career paths, and build meaningful professional networks. If networking
Nov 194 min read


What Ambulatory Care Pharmacists Should Know About 2025 Medicare Part D Updates
Written by Ardis M. Copenhaver, PharmD, MS, BCPS Some of Medicare Part D changes from the passage of Inflation Reduction Act of 2022 have come into effect in January 2025. The goal of this legislation is to provide further support on prescription drug benefits for the adults aged 65 and older and those individuals with qualifying disabilities. The two big 2025 changes include the elimination of the “Donut Hole” with the reduction of out-of-pocket (OOP) costs and the launch of
Nov 124 min read


Expanding Access to Care: Implementation of an Audible Prescription Labeling System (APLS) at Johns Hopkins Community Pharmacies
Written by Ally Rhea, PharmD Candidate 2027; Sai Wright, PharmD, MBA, MSPH; Laurel Uhomba, PharmD, MBA, MPH Nearly 12 million adults over the age of 40 in the United States are living with vision loss, which may significantly impact their ability to manage medications safely.(1) Prescription labels are often printed in small fonts that are not accessible to visually impaired individuals. Without the ability to read medication names, instructions, or warnings, patients may fa
Oct 303 min read


Thriving (Surviving) as a New Ambulatory Care Academic: Finding Your Path in Practice, Teaching, Scholarship, Service, and Life
Written by Chelsea Huppert, PharmD, BCACP; Aaron Brown, PharmD; Christina Berg, PharmD; Jessica Witt, PharmD, BCACP So, you want to be an academic? Maybe you’ve been dreaming about this for years or you fell into this by chance. Maybe you’re new to this or have been practicing for decades. Any which way, you’re here. Now what? The world of academic pharmacy can be intimidating. You have many priorities to balance and people vying for your time. So, how do you start? How do y
Oct 16 min read


Pediatric RSV Prevention Gets an Upgrade in Nirsevimab
Written by Ardis M. Copenhaver, PharmD, MS, BCPS Respiratory syncytial virus (RSV) is a respiratory virus that usually causes cold-like symptoms and tends to occur between the beginning of October and end of March in the United States.(1) It is the most common cause of lower respiratory tract infections in children younger than 1 year of age and the leading cause of hospitalization among infants.(1) The highest rate of hospitalizations occurs during the first months of life w
Sep 194 min read


Updates in Glucagon Prescribing: Essential Tips for Pharmacists
Written by Christina Berg, PharmD; Chelsea Huppert, PharmD, BCACP; Aaron Brown, PharmD Those who remember the tedious process of pulling outdates in their local community pharmacy as a young intern may recall their first encounter with glucagon. Back in the pharmacy, likely in a corner on the bottom shelf, there resided a red plastic kit covered in dust that was almost always expired. If you were filled with curiosity, you may have asked your pharmacist what this was used for
Sep 45 min read


Experiences from the ACCP Leadership and Management Academy
Written by Kathryn P. (Litten) Lin, PharmD, BCACP As an ambulatory care pharmacist and faculty member, I wear many hats—clinician, educator, preceptor, research project manager, and service leader. As a mentor to students and as I stepped into a new leadership role within a professional organization, I recognized I had never had formal leadership training. I knew there were opportunities to hone skills that could aid in several of my professional roles, particularly in financ
Aug 142 min read


Semaglutide for Symptom Management in HFpEF and Related Metabolic Phenotypes
Written by Alex Flores-Xie, PharmD Candidate 2026 and Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS HFpEF: A Growing Challenge Heart Failure (HF) is a heterogenous syndrome defined by structural or functional cardiac abnormalities impairing the heart’s ability to meet metabolic demands.(1,2) HF is classified by left-ventricular ejection fraction (LVEF) into: HF with reduced EF (HFrEF, LVEF <40%), HF with preserved EF (HFpEF, LVEF ≥50%), HF with mildly reduced EF (HFmrEF
Jul 245 min read


Exploring Glucagon-like Peptide-1 receptor agonist (GLP-1 RA) Use in Patients with Cirrhosis
Written by Braylee Wardwell, PharmD and Marissa Salvo, PharmD, BCACP, FCPA, FCCP What is Cirrhosis? Cirrhosis is a condition where healthy liver tissue is replaced by scar tissue. As cirrhosis progresses, scar tissue can block blood flow to the liver and cause liver failure.(1) Leading causes of cirrhosis include hepatitis B and C infections, excessive alcohol consumption, and metabolic dysfunction due to diabetes, obesity, hypertension or lipid disorders. There are two stage
Jul 24 min read


Emergence of SGLT-2 Inhibitor-Induced Myopathy
Written by Qabas Al-Jobori, PharmD Candidate and Adenike Atanda, PharmD, BCACP, CDCES, CTTS Drug-induced myopathy manifests as myalgia, muscle weakness, or, in severe cases , rhabdomyolysis following medication exposure. It may also present as asymptomatic elevation of serum creatine kinase (CK), with resolution achieved following the discontinuation of the offending agent.(1) While mechanisms such as direct myotoxicity and, more rarely, immune-mediated myopathy explain so
Jun 64 min read


Relieving the Pressure: Pulmonary Arterial Hypertension Treatment Review and Updates
Written by Kellie Ball, PharmD, MPH, BCACP and Danielle Dennis, PharmD, BCPS What is Pulmonary Hypertension (PH)? PH is a complex, often fatal condition characterized by abnormally high pressures in the pulmonary arteries caused in large part by smooth muscle and endothelial cell proliferation.(1) If left untreated, these complex and multifactorial processes may lead to right ventricle dysfunction, heart failure, and death.(2) PH describes a group of disorders that fall int
Dec 19, 20245 min read


What’s on the Menu? Nutrition Guidance for Patients with Diabetes
By Wiam Ouahab, PharmD Candidate 2025 and Helen Berlie, BHS, PharmD, BCACP Introduction Medical nutrition therapy (MNT) is essential to...
Dec 6, 20244 min read


From Imposter to Empowered: Overcoming Imposter Syndrome for You and Your Learners
By Megan Makovsky, PharmD Candidate 2025; Nikki Polivka, PharmD Candidate 2025; Kimmy Nguyen, PharmD, BCACP, BC-ADM, TTS Have you ever said to yourself, “ I don’t belong here. Everyone else is so much smarter than me?” That fraudulent feeling is known as imposter syndrome, and nearly 70% of people have experienced it at least once. It primarily affects those who are high-achieving and successful (including those in pharmacy), and it is often characterized by insecurity, self-
Nov 12, 20244 min read


Pharmacist-driven Treatment of Latent Tuberculosis Infection within a Gastroenterology Clinic: A Focus on Patients Requiring High Risk Medication Therapy or Those with Elevated Liver Enzymes
By Sarah Rinehart, PharmD, BCACP Patients with inflammatory bowel disease (IBD) are often treated with biologics or small molecules, including tumor necrosis factor (TNF)–α antagonists and corticosteroids.(1,2) Patients on these regimens with latent tuberculosis infection (LTBI) are at risk for reactivation of Mycobacterium tuberculosis to active tuberculosis (TB) disease.(3) Screening for LTBI using either TB blood tests (Interferon Gamma Release Assays [IGRAs] including
Oct 17, 20245 min read


Exploring Practice Barriers for Psychiatric Pharmacists to Address a Specialty Need
By Alexis Richardson, PharmD Candidate and Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES It is estimated that 20% of adults in the United States experience mental health conditions every year, and 46% of adults aged 18 or older with any mental illness (AMI), received inpatient or outpatient mental health services or took prescription medication to treat a mental health condition in the last year.(1) These conditions include anxiety disorders, depression disorders, attention d
Aug 19, 20245 min read


The Role of GLP-1 Receptor Agonists in Patients with Type 2 Diabetes and Diabetic Kidney Disease – Overview and Updates
By Andrea Lenear, PharmD Candidate 2025 and Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES What is Diabetic Kidney Disease? Chronic kidney...
Jul 22, 20246 min read


The Pharmacist’s Role in Hypertrophic Obstructive Cardiomyopathy
By Dave Ferris, PharmD Hypertrophic Obstructive Cardiomyopathy (HOCM) is a devastating disease and, until recently, had no treatment. With the introduction of mavacamten, symtoms not only improve but disease progression can be reversed. This medication poses significant drug interactions and possible complications. With medication-related expertise, pharmacists have the opportunity to improve patient safety and care for patients with HOCM who initiate this therapy . The
Jun 21, 20244 min read


Running on Empty: Navigating the GLP-1 and GIP/GLP-1 Receptor Agonist Drug Shortage
By Sydnie Twillmann, PharmD Glucagon-like peptide 1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists have been making the headlines recently, for more reasons than one. Over the past few years, due to both appropriate and inappropriate use, the demand for and use of GLP-1 and GIP/GLP-1 receptor agonists have increased substantially, leaving drug manufacturers struggling to keep their supply sufficient to meet these incr
May 27, 20244 min read


ACCESS is Key: Providing Care for Underserved Populations
By Hannah Vitale, PharmD Candidate 2024 and Kimmy Nguyen, PharmD, BCACP, BC-ADM, TTS Introduction In the US, there are over 1,400...
Nov 21, 20234 min read


Advancement in Technology: SmartWatch
By Devon Hess, MBA, PharmD Candidate 2024 and Rachel Long, PharmD, BCPS, CPP, CDCES Advancements in technology have revolutionized...
Nov 6, 20234 min read
bottom of page